VHDL Answers to Frequently Asked Questions

Cohen, Ben

doi:10.1007/978-1-4615-5641-1

Cited by 12 publications

(13 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…No cut-off scores have been established for the scale. Scores acquired on the PSS 4 were used to compare scores between samples using descriptive statistics [ 71 ].…”

Section: Methodsmentioning

confidence: 99%

Psychological Distress in Healthy Low-Risk First-Time Mothers during the Postpartum Period: An Exploratory Study

Murphey

Carter

Price

et al. 2017

Nursing Research and Practice

View full text Add to dashboard Cite

Psychological distress, defined as depression, anxiety, and insomnia in this study, can occur following the birth of a baby as new mothers, in addition to marked physiological changes, are faced with adapting to new roles and responsibilities. We investigated the cooccurrence of stress, depression, anxiety, and insomnia in mothers during the postpartum period; tested the feasibility of study methods and procedures for use in this population; and identified new mothers interest in using cranial electrotherapy stimulation (CES) as an intervention for reducing psychological distress. We recruited healthy, low-risk, English speaking first-time mothers, ages 18–32 years, with healthy babies (N = 33), within 12 months of an uncomplicated birth. Participants completed the PSS, HAM-D14, HAM-A17, and PSQI19. No problems were encountered with study procedures. Mothers reported a high interest (4.9) in the potential use of CES to treat or prevent the occurrence of psychological distress. All participants (N = 33) reported moderate levels of depression and anxiety, while 75.8% (n = 25) reported insomnia. PSS scores were within the norms for healthy women. Further research is recommended to investigate if our findings can be replicated or if different patterns of associations emerge. Implications for clinical practice are addressed.

show abstract

“…No cut-off scores have been established for the scale. Scores acquired on the PSS 4 were used to compare scores between samples using descriptive statistics [ 71 ].…”

Section: Methodsmentioning

confidence: 99%

Psychological Distress in Healthy Low-Risk First-Time Mothers during the Postpartum Period: An Exploratory Study

Murphey

Carter

Price

et al. 2017

Nursing Research and Practice

View full text Add to dashboard Cite

show abstract

“…In addition to in vitro studies indicating its more potent inhibition of norepinephrine transporters, noninferiority RCTs have compared the efficacy (symptom reduction) of desvenlafaxine favorably with venlafaxine and SSRIs. This is evidenced by a similar magnitude of change among experimental groups from baseline to endpoint on mean HAM-D 17 scores compared with placebo [ 39 , 40 ]. Treatment outcome (effectiveness) data have also been positive, with observed remission rates similar to those reported by Thase and colleagues from placebo-controlled venlafaxine studies [ 41 ].…”

Section: Adt: Comparing Classes and Compoundsmentioning

confidence: 96%

Antidepressant efficacy and side-effect burden: a quick guide for clinicians

Santarsieri¹,

Schwartz²

2015

DIC

147

View full text Add to dashboard Cite

Prescribing of antidepressant treatment (ADT) for major depressive disorder (MDD) has increased in quantity and popularity over the last two decades. This is likely due to the approval of safer medications, better education of clinicians and their patients, direct-to-consumer marketing practices, and less stigma associated with those taking ADT. This trend has also been met with some controversy, however, as the ongoing safety and effectiveness of these treatments have at times been called into question. This paper discusses the differing levels of evidence that support the use of ADT based on (A) Food and Drug Administration approvals, (B) data from randomized controlled trials or meta-analyses and, where these are not available, the authors discuss and apply, (C) theoretical pharmacodynamic principles to justify antidepressant choice in the treatment of MDD patients. The final section discusses standard psychopharmacology guideline approaches to better alert the reader as to which practices are commonplace compared with those which are more outside of the standard of care.

show abstract

“…Respondents were then divided into quintiles on the basis of their PSS-10 score. In accordance with the description of the PSS-10, we compared quintiles of stress level [33]. Higher PSS-10 scores indicated a greater feeling of psychological stress [32].…”

Section: Exposurementioning

confidence: 99%

Perceived stress as a risk factor for dyspepsia: a register-based cohort study

Deding

Torp‐Pedersen

Bøggild

2017

European Journal of Gastroenterology &Amp; Hepatology

View full text Add to dashboard Cite

Objective Dyspepsia is a common condition and has a huge impact on quality of life and working capacity, but its causes are not well understood. An association between stress and dyspepsia has been debated for decades, but the issue has not been resolved. We examined the 3-year risk of redeeming a proton-pump inhibitor or an H2-receptor antagonist as a proxy of dyspepsia according to the level of perceived stress. Participants and methods Perceived stress was measured in a general health survey of 16 124 Danes aged older than 16 years of age in 2010 using Cohen’s Perceived Stress Scale. Data were linked individually to national registries, including the Danish National Prescription Registry. The risk of redeeming a proton-pump inhibitor or an H2-receptor antagonist for quintiles of stress level was estimated using Cox proportional hazard regression. Results In total, 2703 redeemed one of these drugs during the 33 months of follow-up. The cumulative incidence proportion of dyspepsia increased gradually, from 11.6 to 24.9%, with quintiles of stress. After full model adjustment, the four highest stress quintiles had a statistically significantly increased risk of redeeming a drug compared with the lowest stress quintile. The hazard ratios were 1.16 [95% confidence interval (CI): 1.00–1.34] for the second quintile, 1.21 (95% CI: 1.06–1.39) for the third quintile, 1.20 (95% CI: 1.05–1.38) for the fourth quintile, and 1.30 (95% CI: 1.12–1.50) for the fifth quintile. Conclusion Higher levels of self-reported perceived everyday life stress increased the risk of redeeming a drug for dyspepsia significantly during 33 months of follow-up.

show abstract

VHDL Answers to Frequently Asked Questions

Cited by 12 publications

References 0 publications

Psychological Distress in Healthy Low-Risk First-Time Mothers during the Postpartum Period: An Exploratory Study

Psychological Distress in Healthy Low-Risk First-Time Mothers during the Postpartum Period: An Exploratory Study

Antidepressant efficacy and side-effect burden: a quick guide for clinicians

Perceived stress as a risk factor for dyspepsia: a register-based cohort study

Contact Info

Product

Resources

About